SlideShare a Scribd company logo
4
Most read
6
Most read
8
Most read
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
The HTA Core Model ®
A brief introduction
Anna Nachtnebel, Ludwig Boltzmann Institute for HTA, Vienna, Austria
Third WP2 Face to Face Training Course for EUnetHTA stakeholders,
Brussels, 23rd of April 2015
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Key Aims of the HTA Core Model
 To capture the shareable „core“ of HTA
 To enable production of structured HTA information
and sharing of acquired knowledge
 To support joint HTA production
 To support local HTA production
April 25, 2013 2
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Starting points
Two problems:
HTA implemented differently across Europe –
reduced applicability of foreign reports
Varying structure of reports – extraction of data from
reports is often difficult
Aim: attempt to defined and standardise elements of an
HTA to facilitate shared understanding of HTA and
promote international use of HTA results
May 8, 2015 3
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
The Domains of the HTA Core Model®
HTA Core Model DOMAINS
1. Health problem and current use of technology
2. Description and technical characteristics
3. Safety
4. Clinical effectiveness
5. Costs and economic evaluation
6. Ethical analysis
7. Organisational aspects
8. Social aspects
9. Legal aspects
SCOPE
Rapid
Full
Reliable,timely,transparent,
transferableHTAinformation
Value???
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Rapid HTA Core Model
55
= checklist for ethical,
organizational, social
and legal issues
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Within each domains – several issues
HTA Core Model DOMAINS
1. Health problem and current use of technology
A0001: For which health conditions, and for what purposes is the
technology used?
A0002: What is the disease or health condition in the scope of this
assessment?
A0003: What are the known risk factors for the disease or health
condition?
4. Clinical effectiveness
D0001:What is the expected beneficial effect of the intervention on mortality?
D0020: Does use of the test lead to improved detection of the condition?
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Core HTAs contain an extensive assessment of health technology through
utilizing all nine domains of HTA included in the HTA Core Model.
Rapid HTAs contain a narrower analysis of health technology, limited to a
subset of domains and performed typically in a faster pace
5 applications:
• Diagnostic technologies
• Medical and surgical interventions
• Pharmaceuticals
• Screening technologies
• Rapid REA (for pharmaceuticals) only first 4 domains are assessed
HTA Core Model
7
Core HTA
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
The Domains of the
HTA Core Model®
HTA Core Model DOMAINS Med Tec Pharma
Diagnosti
cs
Screening
Rapid
REA
1. Health problem and current use of technology
A0001: For which health
conditions, and for what purposes is
the technology used?
critical critical critical critical critical
A0002: What is the disease or
health condition in the scope of this
assessment?
critical critical critical critical critical
A0003: What are the known risk
factors for the disease or health
condition?
important Important important critical
import
ant
4. Clinical effectiveness
D0001:What is the expected
beneficial effect of the intervention on
mortality?
critical Critical critical critical critical
D0020: Does use of the test lead to
improved detection of the condition?
- - important important -
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
 Longer timeframe as a full HTA Core assessment is
conducted - detailed information
 Relevant sets of information for producing a HTA report
– shareable/ transferable information
 HTA core information structured through nine relevant
domains – comprehensive information
 Cross-border collaboration, quality assurance –
reliable and transparent information
Full HTA Core Model
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Rapid HTA Core Model
 Rapid timeframe as assessment characteristics are adapted to national
reimbursement context – timely information
 Similar set of information within the four domains and European
countries – shareable/ transferable information
 A compact and easy-to-read format – useful information
 Cross-border collaboration, quality assurance – reliable and
transparent information
10
European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Thank you!
This presentation arises from the EUnetHTA
Joint Action 2 which has received funding
from the European Union, in the framework of
the Health Programme

More Related Content

PPT
Change Matters: How to Find New Market Space
PPTX
Startup Factory Presentation Jan 2016
PPTX
Why Startups fail and how to avoid it.
PPTX
Digital Marketing in Pharma (India)
PPT
Pharmaceutical Marketing Presentation
PPTX
Socio psychological effect of early marriages
PPT
Working with the Transgender Population: what you need to know
PDF
Careerist pitch deck: $8M for YC-backed EdTech startup
Change Matters: How to Find New Market Space
Startup Factory Presentation Jan 2016
Why Startups fail and how to avoid it.
Digital Marketing in Pharma (India)
Pharmaceutical Marketing Presentation
Socio psychological effect of early marriages
Working with the Transgender Population: what you need to know
Careerist pitch deck: $8M for YC-backed EdTech startup

Viewers also liked (7)

PPT
HTA and evidence-based policy making: the Queensland Health experience
PPTX
How to use HTA for decision-making based on HTA Core Information
PDF
Results of the EUnetHTA Joint Action
PPT
Health Technology Assessment : Interpreting a HTA report
PPTX
Health Technology Assessment (HTA): a tool for evidence-informed decision mak...
PPTX
Healthcare information technology
PDF
Indian healthcare industry presentation
HTA and evidence-based policy making: the Queensland Health experience
How to use HTA for decision-making based on HTA Core Information
Results of the EUnetHTA Joint Action
Health Technology Assessment : Interpreting a HTA report
Health Technology Assessment (HTA): a tool for evidence-informed decision mak...
Healthcare information technology
Indian healthcare industry presentation
Ad

Similar to The HTA Core Model® A brief introduction (20)

PPTX
EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...
PPTX
EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)
PPTX
Brief introduction to EUnetHTA and its tools
PPTX
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...
PDF
{c1708a15-166a-4242-9306-4cbce9f0d948}_4775_18AUG16_PanEuropeanCollaborations
PPTX
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
PPTX
Cadth 2015 d2 warren cadth april_14_2015
PPTX
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA
PPTX
How to use the EUnetHTA submission template to support production of core Hea...
PDF
Jornadas #PatientInHTA · Iñaki Imaz
PPTX
The EUnetHTA perspective on the HTA database
PPT
Health Technology Assessment
PPTX
EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...
PPT
Health technology assessment in the United States
PPT
2014 12-02 hta emro banken 1
PDF
Health technology
PDF
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
PPTX
How can patients and providers best contribute to the HTA process?
PPTX
EUnetHTA Training course for Stakeholders - Choice of Endpoints for Reimburse...
PPT
2014 09-04 hta afrique banken final
EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...
EUnetHTA Training course for Stakeholders - HTA Core Model (r) (Kristian LAMPE)
Brief introduction to EUnetHTA and its tools
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...
{c1708a15-166a-4242-9306-4cbce9f0d948}_4775_18AUG16_PanEuropeanCollaborations
EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...
Cadth 2015 d2 warren cadth april_14_2015
EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA
How to use the EUnetHTA submission template to support production of core Hea...
Jornadas #PatientInHTA · Iñaki Imaz
The EUnetHTA perspective on the HTA database
Health Technology Assessment
EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...
Health technology assessment in the United States
2014 12-02 hta emro banken 1
Health technology
Placing the Evolution of HTA In Emerging Markets in Context of Health System ...
How can patients and providers best contribute to the HTA process?
EUnetHTA Training course for Stakeholders - Choice of Endpoints for Reimburse...
2014 09-04 hta afrique banken final
Ad

Recently uploaded (20)

PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PDF
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPTX
Cardiovascular - antihypertensive medical backgrounds
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PPTX
SKIN Anatomy and physiology and associated diseases
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPT
Management of Acute Kidney Injury at LAUTECH
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PDF
شيت_عطا_0000000000000000000000000000.pdf
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPT
Breast Cancer management for medicsl student.ppt
PPT
ASRH Presentation for students and teachers 2770633.ppt
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Oral Aspect of Metabolic Disease_20250717_192438_0000.pdf
Copy of OB - Exam #2 Study Guide. pdf
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
Cardiovascular - antihypertensive medical backgrounds
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
SKIN Anatomy and physiology and associated diseases
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
Management of Acute Kidney Injury at LAUTECH
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
شيت_عطا_0000000000000000000000000000.pdf
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
Obstructive sleep apnea in orthodontics treatment
surgery guide for USMLE step 2-part 1.pptx
Breast Cancer management for medicsl student.ppt
ASRH Presentation for students and teachers 2770633.ppt

The HTA Core Model® A brief introduction

  • 1. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu The HTA Core Model ® A brief introduction Anna Nachtnebel, Ludwig Boltzmann Institute for HTA, Vienna, Austria Third WP2 Face to Face Training Course for EUnetHTA stakeholders, Brussels, 23rd of April 2015
  • 2. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Key Aims of the HTA Core Model  To capture the shareable „core“ of HTA  To enable production of structured HTA information and sharing of acquired knowledge  To support joint HTA production  To support local HTA production April 25, 2013 2
  • 3. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Starting points Two problems: HTA implemented differently across Europe – reduced applicability of foreign reports Varying structure of reports – extraction of data from reports is often difficult Aim: attempt to defined and standardise elements of an HTA to facilitate shared understanding of HTA and promote international use of HTA results May 8, 2015 3
  • 4. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu The Domains of the HTA Core Model® HTA Core Model DOMAINS 1. Health problem and current use of technology 2. Description and technical characteristics 3. Safety 4. Clinical effectiveness 5. Costs and economic evaluation 6. Ethical analysis 7. Organisational aspects 8. Social aspects 9. Legal aspects SCOPE Rapid Full Reliable,timely,transparent, transferableHTAinformation Value???
  • 5. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Rapid HTA Core Model 55 = checklist for ethical, organizational, social and legal issues
  • 6. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Within each domains – several issues HTA Core Model DOMAINS 1. Health problem and current use of technology A0001: For which health conditions, and for what purposes is the technology used? A0002: What is the disease or health condition in the scope of this assessment? A0003: What are the known risk factors for the disease or health condition? 4. Clinical effectiveness D0001:What is the expected beneficial effect of the intervention on mortality? D0020: Does use of the test lead to improved detection of the condition?
  • 7. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Core HTAs contain an extensive assessment of health technology through utilizing all nine domains of HTA included in the HTA Core Model. Rapid HTAs contain a narrower analysis of health technology, limited to a subset of domains and performed typically in a faster pace 5 applications: • Diagnostic technologies • Medical and surgical interventions • Pharmaceuticals • Screening technologies • Rapid REA (for pharmaceuticals) only first 4 domains are assessed HTA Core Model 7 Core HTA
  • 8. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu The Domains of the HTA Core Model® HTA Core Model DOMAINS Med Tec Pharma Diagnosti cs Screening Rapid REA 1. Health problem and current use of technology A0001: For which health conditions, and for what purposes is the technology used? critical critical critical critical critical A0002: What is the disease or health condition in the scope of this assessment? critical critical critical critical critical A0003: What are the known risk factors for the disease or health condition? important Important important critical import ant 4. Clinical effectiveness D0001:What is the expected beneficial effect of the intervention on mortality? critical Critical critical critical critical D0020: Does use of the test lead to improved detection of the condition? - - important important -
  • 9. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu  Longer timeframe as a full HTA Core assessment is conducted - detailed information  Relevant sets of information for producing a HTA report – shareable/ transferable information  HTA core information structured through nine relevant domains – comprehensive information  Cross-border collaboration, quality assurance – reliable and transparent information Full HTA Core Model
  • 10. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Rapid HTA Core Model  Rapid timeframe as assessment characteristics are adapted to national reimbursement context – timely information  Similar set of information within the four domains and European countries – shareable/ transferable information  A compact and easy-to-read format – useful information  Cross-border collaboration, quality assurance – reliable and transparent information 10
  • 11. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Thank you! This presentation arises from the EUnetHTA Joint Action 2 which has received funding from the European Union, in the framework of the Health Programme

Editor's Notes

  • #2: Title slide yellow
  • #5: Table slide
  • #6: Text slide fact
  • #7: Table slide
  • #9: Table slide